Ability of Bacteriophage in Resolving Wound Infection Caused by Multidrug-Resistant Acinetobacter baumannii in Uncontrolled Diabetic Rats

Microbial Drug Resistance

Volumn 21, Issue 2, 2015, Pages 171-177

  Shivaswamy, Vinodkumar Chickmangalure ^a   Kalasuramath, Suneeta Basavaraj ^a   Sadanand, Chethan Kumar ^a   Basavaraju, Abhishek Kilagere ^a   Ginnavaram, Varsha ^a   Bille, Sumanth ^a   Ukken, Sanjay Saju ^a   Pushparaj, Usha Nandini ^a  

^a SS Institute of Medical Sciences and Research Centre   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; COLISTIN; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BACTERIOPHAGE; CONTROLLED STUDY; DIABETES MELLITUS; EPITHELIZATION; MALE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; RAT; WOUND CONTRACTION; WOUND INFECTION; ACINETOBACTER INFECTIONS; ANIMAL; CROSS INFECTION; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PROCEDURES; VIROLOGY; WISTAR RAT;

ACINETOBACTER BAUMANNII; BACTERIA (MICROORGANISMS); RATTUS;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIOPHAGES; BETA-LACTAMASES; COLISTIN; CROSS INFECTION; DIABETES MELLITUS, EXPERIMENTAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; MALE; MICROBIAL SENSITIVITY TESTS; RATS; RATS, WISTAR; WOUND INFECTION;

EID: 84925953683     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2014.0120     Document Type: Article

References (29)

1. Abbo, A. , Y. Carmeli, S. Navon-Venezia, Y. Siegman-Igra, and M. J. Schwaber. 2007. Impact of multi-drugresistant Acinetobacter baumannii on clinical outcomes. Eur. J. Clin. Microbiol. Infect. Dis. 26:793-800.
2. Ananthakrishnan, A. N. , R. Kanungo, A. Kumar, and S. Badrinath. 2004. Detection of extended spectrum blactamase producers among surgical wound infections and burn patients in JIPMER. Ind. J. Med. Microbiol. 18:160-165.
3. Antunes, L. C. , F. Imperi, A. Carattoli, and P. Visca. 2011. Deciphering the multifactorial nature of Acinetobacter baumannii pathogenicity. PLoS One 6:e22674.
4. Bauer, A. W. , W. M. Kirby, J. C. Sherri, and M. Turkek. 1966. Antibiotic susceptibility testing methods. Am. J. Clin. Pathol. 45:493-498.
5. Bojovazova, G. G. , N. N. Voroshilova, and V. M. Bondarenko. 1991. The efficacy of Klebsiella bacteriophage in the therapy of experimental Klebsiella infection. J. Microbiol. Epidemiol. Immunobiol. 4:5-8.
6. Chu, Y.-W. , M. Afzal-Shah, E. T. S. Houang, M.-F. I. Palepou, D. J. Lyon, N. Woodford, and D. M. Livermore. 2001. IMP-4, a novel metallo-b-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998. Antimicrob. Agents Chemother. 45:710-714.
7. Deirdre, C. , M. Elizabeth, and U. Barbara. 2000. Quantitative Gram stain interpretation criteria used by microbiology laboratory in Alberta, Canada. J. Clin. Microbiol. 12:42662-42668.
8. Dijkshoorn, L. , A. Nemec, and H. Seifert. 2007. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol. 12:939-951.
9. Dwajani, S. , and T. Shanbhag. 2009. Michelia champaca: wound healing activity in immunosuppressed rats. Internet J. Altern. Med. 7:128-132.
10. Haq, I. U. W. W. Chaudhry, M. N. Akhtar, S. Andleeb, and I. Qadri. 2012. Bacteriophages and their implications on future biotechnology: a review. Virol. J. 9:9-17.
11. Jin, J. , Z. J. Li, S. W. Wang, S. M. Wang, D. H. Huang, Y. H. Li, Y. Y. Ma, J. Wang, F. Liu, X. D. Chen, G. X. Li, X. T. Wang, Z. Q. Wang, and G. Q. Zhao. 2012. Isolation and characterization of ZZ1, a novel lytic phage that infects Acinetobacter baumannii clinical isolates. BMC Microbiol. 12:156-164.
12. Joao, J. M. , C. Leandro, S. Corte-Real, R. Barbosa, P. Cavaco Silva, J. Melo Cristino, A. Gorski, and M. Garcia. 2013. Wound healing potential of topical bacteriophage therapy on diabetic cutaneous wounds. Wound Repair Regen. 21:595-603.
13. Kumar, M. S. , V. Lakshmi, and R. Rajagopalan. 2006. Occurrence of extended spectrum b-lactamases among Enterobacteriaceae species isolated at a tertiary care institute. Indian J. Med. Microbial. 24:208-211.
14. Lenzen, S. 2008. The mechanisms of alloxan and streptozotocin induced diabetes. Diabetologica 51:216-226.
15. Lin, N. T. , et al. 2010. Isolation and characterization of phi AB2: a novel bacteriophage of Acinetobacter baumannii. Res. Microbiol. 161:308-314.
16. Lood, R. , M. Morgelin, A. Holmberg, M. Rasmussen, and M. Collin. 2008. Inducible Siphoviruses in superficial and deep tissue isolates of Propionibacterium acnes. BMC Microbiol. 8:139.
17. McConnell, M. J. , et al. 2012. Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models. FEMS Microbiol. Rev. 37:130-155.
18. Muppayavarmath, S. S. , and P. A. Patil. 1999. The influence of tricyclic antidepressants on resutured incision &deep space wound healing. Indian J. Pharmacol. 31:290-293.
19. Oi, K. , H. Komori, and H. Kajimura. 1997. Changes in plasma glucose, insulin, glucagon, cathecolmine, and glicogen contentes in tissue during development of alloxan diabetes in rats. Biochem. Mol. Med. 62:70-75.
20. Popova, A. V. , et al. 2012. Isolation and characterization of wide host range lytic bacteriophage AP22 infecting Acinetobacter baumannii. FEMS Microbiol. Lett. 332:40-46.
21. Rasha, A. Alm El-Din, H. Ei-Bassat, M. E1-Bedewy, and H. El-Mohamady. 2014. Prevalence of metallo betalactamases producers among carbapenem resistant Acinetobacter baumannii strains isolated from diabetic foot ulcers. Afr. J. Microbiol. Res. 8:1580-1585.
22. Slopek, S. , I. Durlakowa, B. Weber-Dabrowska, A. Kucharewicz-Krukowska, M. Dabrowski, and R. Bisikiewicz. 1983. Results of bacteriophage treatment of suppurative bacterial infections. I. General evaluation of the results. Arch. Immunol. Ther. Exp. 31:267-291.
23. Smith, H. W. , and M. B. Huggins. 1982. Successful treatment of experimental E. coli infections in mice using phage; its superiority over antibiotics. J. Gen. Microbiol. 128:307-318.
24. Steven H. , A. Habel, and U. Blash. 2006. Augmentation of antimicrobial efficacy of antibiotics by filamentous phage. Microb. Drug Resist. 12:164-168.
25. Valencia, R. , et al. 2009. Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital. Infect. Control Hosp. Epidemiol. 30:257-263.
26. Vila, J. , and J. Pachon. 2008. Therapeutic options for Acinetobacter baumannii infections. Expert Opin. Pharmacother. 9:587-599.
27. VinodKumar, C. S. , H. Srinivasa, K. G. Basavarajappa, P. Umakanth, B. Nitin, and P. Rajashri. 2011. Abrogation of Staphylococcus aureus wound infection by bacteriophage in diabetic rats. Int. J. Pharm. Drug Res. 3: 202-207.
28. VinodKumar, C. S. , K. Suneeta, and Y. F. Neelagund. 2008. Utility of lytic bacteriophage in the treatment of multidrug resistant Pseudomonas aeruginosa septicemia in mice. Ind. J. Pathol. Microbiol. 51:360-366.
29. Yang, H. , et al. 2012. Isolation and characterization of a virulent bacteriophage AB1 of Acinetobacter baumannii. BMC Microbiol. 10:131.